Testing effectiveness (Phase 2)Study completedNCT00139711
What this trial is testing
Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer
Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 138